Emmaus Life Sciences, Inc. General form of registration statement for all companies including face-amount certificate companies

Proceeds from issuance of private placement | $

23,000

102,000

152,250

10,000

$ 2,981,300

Value of shares issued | $

$ 2,981,300

2012 Omnibus Incentive Compensation Plan [Member]

Number of options authorized | shares

500,000

200,000

75,000

27,500

1,667

Description of plan terms

(i) increase the total number of shares of Common Stock available for grant under the 2012 Plan from 75,000 shares to an aggregate of 500,000 shares, (ii) add an "evergreen" provision which, on January 1 of each year through 2022, automatically increases the number of shares subject to the 2012 Plan by the lesser of: (a) a number equal to 10% of the shares of Common Stock authorized under the 2012 Plan as of the preceding December 31st, or (b) an amount, or no amount, as determined by the Board, but in no event may the number of shares of Common Stock authorized under the 2012 Plan exceed 885,781 and (iii) increase the annual individual award limits under the 2012 Plan to 100,000 shares of Common Stock, subject to adjustment in accordance with the 2012 Plan;

(i) increase the total number of shares of Common Stock available for grant under the 2012 Plan from 200,000 shares to an aggregate of 500,000 shares, (ii) add an "evergreen" provision which, on January 1st of each year through 2022, automatically increases the number of shares subject to the 2012 Plan by the lesser of: (a) a number equal to 10% of the shares of Common Stock authorized under the 2012 Plan as of the preceding December 31st, or (b) an amount, or no amount, as determined by the Board, but in no event may the number of shares of Common Stock authorized under the 2012 Plan exceed 885,781 and (iii) increase the annual individual award limits under the 2012 Plan to 100,000 shares of Common Stock, subject to adjustment in accordance with the 2012 Plan.

50,000

1,250

Weighted exercise price of awarded shares (in dollars per share)

The option vesting is contingent upon the achievement of agreed upon goals.

$ 8.94

Three-Month Long Consulting Engagement With Dr. Eric Warner [Member]

Monthly professional fees | $

250,000

$ 30,000

Master Purchase and Option Agreement [Member[ | Subsequent Event [Member] | Arcadian Telepsychiatry LLC (''Arcadian'') [Member]

Amount of capital contribution | $

1,000

$ 100,000

Shares issued (in dollars per share)

$ 5.90

Value of shares issued | $

$ 5,900

Consulting Agreement [Member] | Subsequent Event [Member] | AI & J Media, Inc. [Member]

Monthly professional fees | $

$ 10,000

Number of shares issued upon services | shares

5,000

Common Stock [Member]

Value of shares issued | $

477,000

$ 500

Number of shares issued upon services | shares

20,000

Aspire Capital Fund, LLC, an Illinois Limited Liability Company [Member] | Common Stock [Member] | Purchase Notice [Member]

Description of purchase price

1)	the lowest sale price of the Company’s common stock on the purchase date; or

2)	the arithmetic average of the three (3) lowest closing sale prices for the Company’s common stock during the twelve (12) consecutive trading days ending on the trading day immediately preceding the purchase date.

Purchase price (in dollars per share)

$ 0.50

Aspire Capital Fund, LLC, an Illinois Limited Liability Company [Member] | Common Stock [Member] | Purchase Notice [Member] | Maximum [Member]

Common stock issued price per share

$ 0.50

Number of common stock issued per business day | shares

50,000

Aspire Capital Fund, LLC, an Illinois Limited Liability Company [Member] | Common Stock [Member] | Purchase Agreement [Member]

Purchase agreement term

30 months

Aspire Capital Fund, LLC, an Illinois Limited Liability Company [Member] | Common Stock [Member] | Purchase Agreement [Member] | Maximum [Member]

Aspire Capital Fund, LLC, an Illinois Limited Liability Company [Member] | Common Stock ("Commitment Shares") [Member] | Purchase Agreement [Member]

10,000,000

80,000

Staff Members [Member]

102,000

Weighted exercise price of awarded shares (in dollars per share)

Vest pro-rata over 12 months starting on the date of grant.

$ 6.00

Staff Members [Member] | 2012 Omnibus Incentive Compensation Plan [Member]

5,000

102,000

7,250

Mr. George Carpenter & Mr. Paul Buck [Member]

Options vest pro-rata over 36 months starting on the date of grant.

Options vest pro-rata over 12 months starting on the date of grant.

These shares vest pro-rata over 12 months starting on the date of grant.

Weighted exercise price of awarded shares (in dollars per share)

50% vested on the date of grant and the remaining 50% vest pro rata over twelve months starting on the date of grant.

$ 5.10

Mr. Robin L. Smith [Member]

Purchase price (in dollars per share)

$ 6.25

Mr. Robin L. Smith [Member] | 2012 Omnibus Incentive Compensation Plan [Member]

Mr. George Carpenter [Member] | 2012 Omnibus Incentive Compensation Plan [Member]

(a) 20% vested on the date of grant, (b) 20% vested upon receiving CMS approval to bill Medicare, (c) 20% will vest upon signing a healthcare system to use our PEER technology, (d) 20% will vest upon signing a multi-practitioner group to use our PEER technology, and (e) 20% will vest upon up-listing to an exchange in 1 year.

Mr. Paul Buck [Member] | 2012 Omnibus Incentive Compensation Plan [Member]

a) 25% vested on the date of grant, (b) 25% vested on the date that we received CNS approval to bill Medicare, (c) 25% will vest upon signing a healthcare system to use our PEER technology and (d) 25% will vest upon signing a multi-practitioner group to use our PEER technology.